4.8 Review

Deconstructing Mechanisms of Diet-Microbiome-Immune Interactions

期刊

IMMUNITY
卷 53, 期 2, 页码 264-276

出版社

CELL PRESS
DOI: 10.1016/j.immuni.2020.07.015

关键词

-

资金

  1. National Institutes of Health [R01HL122593, R21CA227232, R01AR074500, 5T32AI060537, 1F32AI147456]
  2. Damon Runyon Cancer Research Foundation [DRR42-16]
  3. Searle Scholars Program [SSP-2016-1352]

向作者/读者索取更多资源

Emerging evidence suggests that the effect of dietary intake on human health and disease is linked to both the immune system and the microbiota. Yet, we lack an integrated mechanistic model for how these three complex systems relate, limiting our ability to understand and treat chronic and infectious disease. Here, we review recent findings at the interface of microbiology, immunology, and nutrition, with an emphasis on experimentally tractable models and hypothesis-driven mechanistic work. We outline emerging mechanistic concepts and generalizable approaches to bridge the gap between microbial ecology and molecular mechanism. These set the stage for a new era of precision human nutrition informed by a deep and comprehensive knowledge of the diverse cell types in and on the human body.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Microbiology

Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation

Renuka R. Nayak, Margaret Alexander, Ishani Deshpande, Kye Stapleton-Gray, Bipin Rimal, Andrew D. Patterson, Carles Ubeda, Jose U. Scher, Peter J. Turnbaugh

Summary: Immunomodulatory drug MTX can broadly alter human gut microbiota, especially in RA patients, with distinct effects on bacterial taxa and gene abundance between responders and non-responders. Transplantation of post-treatment samples into germ-free mice shows reduced immune activation, identifying MTX-modulated bacterial taxa associated with intestinal and splenic immune cells.

CELL HOST & MICROBE (2021)

Article Rheumatology

The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New-Onset Rheumatoid Arthritis

Alejandro Artacho, Sandrine Isaac, Renuka Nayak, Alejandra Flor-Duro, Margaret Alexander, Imhoi Koo, Julia Manasson, Philip B. Smith, Pamela Rosenthal, Yamen Homsi, Percio Gulko, Javier Pons, Leonor Puchades-Carrasco, Peter Izmirly, Andrew Patterson, Steven B. Abramson, Antonio Pineda-Lucena, Peter J. Turnbaugh, Carles Ubeda, Jose U. Scher

Summary: This study investigated the potential of the human gut microbiome in predicting methotrexate (MTX) efficacy in new-onset rheumatoid arthritis (RA) patients. The analysis revealed significant associations between gut bacterial taxa abundance and genes with future clinical response, as well as a microbiome-based model that predicted lack of response to MTX. Ex vivo experiments also suggested a possible direct effect of the gut microbiome on MTX metabolism and treatment outcomes, supporting the value of the gut microbiome as a potential prognostic tool and therapeutic target in RA.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Microbiology

Human gut bacterial metabolism drives Th17 activation and colitis

Margaret Alexander, Qi Yan Ang, Renuka R. Nayak, Annamarie E. Bustion, Moriah Sandy, Bing Zhang, Vaibhav Upadhyay, Katherine S. Pollard, Susan Lynch, Peter J. Turnbaugh

Summary: The activation of Th17 cells by human gut bacteria Eggerthella lenta exacerbates inflammatory bowel disease. Variations in E. lenta strains and the Cgr2 enzyme contribute to Th17 cell activation. Blocking E. lenta-induced intestinal inflammation is crucial for preventing the development of autoimmune diseases.

CELL HOST & MICROBE (2022)

Article Biochemistry & Molecular Biology

Reporting guidelines for human microbiome research: the STORMS checklist

Chloe Mirzayi, Audrey Renson, Fatima Zohra, Shaimaa Elsafoury, Ludwig Geistlinger, Lora J. Kasselman, Kelly Eckenrode, Janneke van de Wijgert, Amy Loughman, Francine Z. Marques, David A. MacIntyre, Manimozhiyan Arumugam, Rimsha Azhar, Francesco Beghini, Kirk Bergstrom, Ami Bhatt, Jordan E. Bisanz, Jonathan Braun, Hector Corrada Bravo, Gregory A. Buck, Frederic Bushman, David Casero, Gerard Clarke, Maria Carmen Collado, Paul D. Cotter, John F. Cryan, Ryan T. Demmer, Suzanne Devkota, Eran Elinav, Juan S. Escobar, Jennifer Fettweis, Robert D. Finn, Anthony A. Fodor, Sofia Forslund, Andre Franke, Cesare Furlanello, Jack Gilbert, Elizabeth Grice, Benjamin Haibe-Kains, Scott Handley, Pamela Herd, Susan Holmes, Jonathan P. Jacobs, Lisa Karstens, Rob Knight, Dan Knights, Omry Koren, Douglas S. Kwon, Morgan Langille, Brianna Lindsay, Dermot McGovern, Alice C. McHardy, Shannon McWeeney, Noel T. Mueller, Luigi Nezi, Matthew Olm, Noah Palm, Edoardo Pasolli, Jeroen Raes, Matthew R. Redinbo, Malte Ruhlemann, R. Balfour Sartor, Patrick D. Schloss, Lynn Schriml, Eran Segal, Michelle Shardell, Thomas Sharpton, Ekaterina Smirnova, Harry Sokol, Justin L. Sonnenburg, Sujatha Srinivasan, Louise B. Thingholm, Peter J. Turnbaugh, Vaibhav Upadhyay, Ramona L. Walls, Paul Wilmes, Takuji Yamada, Georg Zeller, Mingyu Zhang, Ni Zhao, Liping Zhao, Wenjun Bao, Aedin Culhane, Viswanath Devanarayan, Joaquin Dopazo, Xiaohui Fan, Matthias Fischer, Wendell Jones, Rebecca Kusko, Christopher E. Mason, Tim R. Mercer, Susanna-Assunta Sansone, Andreas Scherer, Leming Shi, Shraddha Thakkar, Weida Tong, Russ Wolfinger, Christopher Hunter, Nicola Segata, Curtis Huttenhower, Jennifer B. Dowd, Heidi E. Jones, Levi Waldron

Summary: The STORMS tool is a reporting guideline for human microbiome studies, consisting of a 17-item checklist to help researchers report study results concisely and completely, facilitating manuscript preparation, peer review, and reader comprehension.

NATURE MEDICINE (2021)

Article Cell Biology

Phage-delivered CRISPR-Cas9 for strain-specific depletion and genomic deletions in the gut microbiome

Kathy N. Lam, Peter Spanogiannopoulos, Paola Soto-Perez, Margaret Alexander, Matthew J. Nalley, Jordan E. Bisanz, Renuka R. Nayak, Allison M. Weakley, Feiqiao B. Yu, Peter J. Turnbaugh

Summary: The study demonstrates the use of engineered bacteriophage M13 to deliver DNA to Escherichia coli in the mouse gastrointestinal tract, enabling strain-specific depletion and genomic deletions. Multiple mechanisms allow E. coli to escape targeting, providing a foundation for microbiome editing and suggesting potential for extension to other phage-bacterial pairs.

CELL REPORTS (2021)

Article Biology

The East Asian gut microbiome is distinct from colocalized White subjects and connected to metabolic health

Qi Yan Ang, Diana L. Alba, Vaibhav Upadhyay, Jordan E. Bisanz, Jingwei Cai, Ho Lim Lee, Eliseo Barajas, Grace Wei, Cecilia Noecker, Andrew D. Patterson, Suneil K. Koliwad, Peter J. Turnbaugh

Summary: A study of lean and obese East Asian and White participants in the San Francisco Bay Area revealed significant differences in gut microbiota between the two ethnic groups, which were associated with host body composition. Microbiome transplantations into germ-free mice showed stable, diet- and host genotype-independent differences between the gut microbiotas of East Asian and White individuals, impacting host body composition. These findings highlight the potential importance of ethnicity in microbiome studies and personalized treatments.
Meeting Abstract Biochemistry & Molecular Biology

PThe tiny pharmacists within: How the microbiome impacts the treatment of human disease

Peter J. Turnbaugh

FASEB JOURNAL (2022)

Article Multidisciplinary Sciences

Human gut bacteria produce TH17-modulating bile acid metabolites

Donggi Paik, Lina Yao, Yancong Zhang, Sena Bae, Gabriel D. D'Agostino, Minghao Zhang, Eunha Kim, Eric A. Franzosa, Julian Avila-Pacheco, Jordan E. Bisanz, Christopher K. Rakowski, Hera Vlamakis, Ramnik J. Xavier, Peter J. Turnbaugh, Randy S. Longman, Michael R. Krout, Clary B. Clish, Fraydoon Rastinejad, Curtis Huttenhower, Jun R. Huh, A. Sloan Devlin

Summary: This study identifies bile acids produced by gut bacteria that inhibit the differentiation of T(H)17 cells, a key immune cell type involved in inflammatory disorders such as inflammatory bowel disease. The levels of these bile acids are reduced in patients with inflammatory bowel disease and are inversely correlated with the expression of T(H)17-cell-associated genes.

NATURE (2022)

Article Multidisciplinary Sciences

Synthetic glycans control gut microbiome structure and mitigate colitis in mice

Andrew C. Tolonen, Nicholas Beauchemin, Charlie Bayne, Lingyao Li, Jie Tan, Jackson Lee, Brian Meehan, Jeffrey Meisner, Yves Millet, Gabrielle LeBlanc, Robert Kottler, Erdmann Rapp, Chris Murphy, Peter J. Turnbaugh, Geoffrey von Maltzahn, Christopher M. Liu, Johan E. T. van Hylckama Vlieg

Summary: The authors characterized the properties of chemically diverse synthetic glycans (SGs) in modulating the gut microbiome and demonstrated their therapeutic potential in mouse models of colonic inflammation. The study suggests that SGs could be a promising avenue for treating diseases by altering the composition and metabolites produced by the gut microbiome.

NATURE COMMUNICATIONS (2022)

Article Microbiology

Effects of caloric restriction on the gut microbiome are linked with immune senescence

Julia Sbierski-Kind, Sophia Grenkowitz, Stephan Schlickeiser, Arvid Sandforth, Marie Friedrich, Desiree Kunkel, Rainer Glauben, Sebastian Brachs, Knut Mai, Andrea Thuermer, Aleksandar Radonic, Oliver Drechsel, Peter J. Turnbaugh, Jordan E. Bisanz, Hans-Dieter Volk, Joachim Spranger, Reiner Jumpertz von Schwartzenberg

Summary: Caloric restriction can improve metabolic health, reduce body fat accumulation, and enhance glucose tolerance, while delaying immune senescence by reducing specific cellular immune responses. This suggests that modulation of the gut microbiome could lead to the development of new therapeutic options for metabolic diseases.

MICROBIOME (2022)

Editorial Material Microbiology

Designed secretion deters microbiome depletion

Christine A. Olson, Peter J. Turnbaugh

Summary: Bacteria can be modified to degrade antibiotics in the gut, which helps to maintain colonization resistance against pathogenic bacteria and limit the spread of antibiotic resistance genes in mice.

NATURE MICROBIOLOGY (2022)

Article Oncology

Associations between the Gut Microbiota, Race, and Ethnicity of Patients with Colorectal Cancer: A Pilot and Feasibility Study

Sorbarikor Piawah, Than S. Kyaw, Kai Trepka, Anita L. Stewart, Rosa V. Mora, Dalila Stanfield, Kendall Levine, Erin L. Van Blarigan, Alan Venook, Peter J. Turnbaugh, Tung Nguyen, Chloe E. Atreya, Kekoa Taparra

Summary: The study investigates the relationship between the gut microbiome and colorectal cancer disparities in different racial and ethnic groups. The findings suggest that there are associations between gut microbial composition and race and ethnicity, highlighting the feasibility of analyzing the links between gut microbes and colorectal cancer disparities.

CANCERS (2023)

Article Medicine, Research & Experimental

Microbial signals, MyD88, and lymphotoxin drive TNF-independent intestinal epithelial tissue damage

Iulia Rusu, Elvira Mennillo, Jared L. Bain, Zhongmei Li, Xiaofei Sun, Kimberly M. Ly, Yenny Y. Rosli, Mohammad Naser, Zunqiu Wang, Rommel Advincula, Philip Achacoso, Ling Shao, Bahram Razani, Ophir D. Klein, Alexander Marson, Jessie A. Turnbaugh, Peter J. Turnbaugh, Barbara A. Malynn, Averil Ma, Michael G. Kattah

Summary: Anti-TNF therapy is effective for treating inflammatory bowel disease (IBD), but some patients don't respond well to this treatment. In this study, researchers found that the deletion of certain genes in intestinal epithelial cells (IECs) can sensitize mice to both TNF-dependent and TNF-independent cell death. The study also showed that microbial signals, MyD88, and LT alpha all contribute to the TNF-independent intestinal injury. These findings highlight the importance of TNF-independent pathways in the development of IBD and suggest potential targets for therapy.

JOURNAL OF CLINICAL INVESTIGATION (2022)

暂无数据